Update Management of Diabetes Mellitus

Importance of PPG control and Guidelines & recommendations on PPG control

Insulin faster aspart: the solid foundation from the molecular insight & ONSET® trial

Non-comparable biologics vs originator insulin Risk and controversies

Initiation & Intensification of Insulin with BIAsp 30

IDegAsp: The power of innovation & patient empowerment with simple co-formulation

Insulin IDeg (Tresiba) overview

SUSTAIN Clinical Development Program

Experiences with Liraglutide in Type-2 DM

Explore the Next Generation Insulin Glargine– Toujeo

Role of basal supported oral therapy (BOT) in diabetic patient management

Cardio-Renal-Metabolic Outcomes with SGLT2- Inhibition Empowering the Foundation of T2DM Care

Interpreting ADA Updates from Real World Evidence EMPRISE- Implications for Clinical Practice

Update in Practical management of DM during Ramadan

COVID-19 and diabetes: a bad marriage

Importance of Controlling Diabetes Early-“Metabolic Memory & Legacy Effect”: Evolving Concepts

Update in the management of Type-2 DM with SGLT-2 Inhibitors

Dulaglutide: Personalizing therapy to improve glycaemic and extra-glycaemic outcomes

T2DM Management: Recommendation for COVID-19 & Safe Fasting During Ramadan